Here are Tuesday's top research calls, including downgrades for Amazon and C.R. Bard, and new coverage of CyrusOne and Dow Chemical.
A bullish market and another quant upgrade could push BSX past our $31 target.
Full-steam ahead for earnings season in the coming week as a range of industry leaders across a swath of sectors release their recent quarterly performances.
Canaccord is bullish on Edwards Lifescience stock.